Cargando…

Expression and Clinical Significance of Tumor Necrosis Factor Receptor-Associated Factor 6 in Patients With Colon Cancer

BACKGROUND: Tumor necrosis factor receptor-associated factor 6 (TRAF6) has been reported to be highly expressed in many tumor tissues, but it is still of value to detect its expression in patients with colon cancer and to clarify its clinical significance. OBJECTIVES: To study the expression and cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tao, Wang, Hui, Han, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752796/ https://www.ncbi.nlm.nih.gov/pubmed/26889392 http://dx.doi.org/10.5812/ircmj.23931

Ejemplares similares

Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum
por: Yan, Mei, et al.
Publicado: (2021)

Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction
por: Schwandner, Ralf, et al.
Publicado: (2000)

The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)
por: Muzio, Marta, et al.
Publicado: (1998)

Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6
por: Häcker, Hans, et al.
Publicado: (2000)

Associations of Gastrointestinal Tract Tumor Necrosis Factor Receptor-Associated Factor 6 Expression with Clinical Features and Prognosis of Eosinophilic Gastroenteritis
por: Bai, Yaya, et al.
Publicado: (2023)

Role of tumor necrosis factor receptor-associated factor 6 in pyroptosis during acute pancreatitis
por: Wei, Biwei, et al.
Publicado: (2021)

Interleukin (IL) -1 β, IL-6 and tumor necrosis factor in patients with seasonal flu
por: Ramos, José M., et al.
Publicado: (2018)

Stimulus-dependent Synergism of the Antiapoptotic Tumor Necrosis Factor Receptor–associated Factor 2 (TRAF2) and Nuclear Factor κB Pathways
por: Lee, Soo Young, et al.
Publicado: (1998)

Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis
por: Zhu, Lang-Jing, et al.
Publicado: (2012)

Tumor Necrosis Factor Production and Colon Cancer
por: Ito, Hisashi, et al.
Publicado: (1996)

Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis
por: Caulin, Carlos, et al.
Publicado: (2000)

Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
por: Stachon, Peter, et al.
Publicado: (2010)

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors
por: Pronk, Cornelis J.H., et al.
Publicado: (2011)

Clinical significance of tumor necrosis factor-alpha and carcinoembryonic antigen in gastric cancer
por: Roșu, Mihai Cătălin, et al.
Publicado: (2022)

Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma
por: Yang, Dong, et al.
Publicado: (2018)

Pathogenic Functions of Tumor Necrosis Factor Receptor-Associated Factor 6 Signaling Following Traumatic Brain Injury
por: Huang, Huan, et al.
Publicado: (2021)

Regulation of the calcium-sensing receptor expression by 1,25-dihydroxyvitamin D(3), interleukin-6, and tumor necrosis factor alpha in colon cancer cells()
por: Fetahu, Irfete S., et al.
Publicado: (2014)

Simultaneous Improvement of Cutaneous Sarcoidosis and Psoriasis Vulgaris on Administration of a Tumor Necrosis Factor Alpha Inhibitor
por: Kim, Young Shin, et al.
Publicado: (2023)

Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors
por: Ruby, Janet, et al.
Publicado: (1997)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor
por: Regamey, Alexandre, et al.
Publicado: (2003)

Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
por: Park, Siyeon, et al.
Publicado: (2019)

Expression and Association of Tumor Necrosis Factor Receptor Associated Factor 4 (TRAF4) in Esophageal Squamous Cell Carcinoma
por: Li, Peng-Cheng, et al.
Publicado: (2019)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
por: Hahne, Michael, et al.
Publicado: (1998)

Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor
por: Takahashi, Nozomi, et al.
Publicado: (1999)

A Mediator Role For Metallothionein in Tumor Necrosis Factor–induced Lethal Shock
por: Waelput, Wim, et al.
Publicado: (2001)

Type I interferon drives tumor necrosis factor–induced lethal shock
por: Huys, Liesbeth, et al.
Publicado: (2009)

Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation
por: Zucchelli, Silvia, et al.
Publicado: (2011)

Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis
por: SanMiguel, Jennifer M., et al.
Publicado: (2022)

A significant role for tumor necrosis factor in Nlrp3 inflammasomeopathies
por: McGeough, M, et al.
Publicado: (2015)

Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
por: Bansback, Nick, et al.
Publicado: (2020)

Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021)

A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth
por: Rennert, Paul, et al.
Publicado: (2000)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism
por: Zhang, Lei, et al.
Publicado: (2018)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2k32594tsmq1759hbbnof7rkeb